ANTI-CANCER PRODRUG FOR OVERCOMING MULTIDRUG RESISTANCE

摘要

The present invention relates to an anti-cancer prodrug comprising a compound represented by [Formula 1] as stated below: The anti-cancer prodrug, according to the present invention, has high selectivity for cancer cells overexpressing COX-2, and selectively reacts to H₂O₂ and effectively releases two drugs, thereby overcoming multidrug resistance and improving anti-cancer effects.